George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 41,708 shares at $43.92 ($1.8M) on 2022-08-09, disclosed to the SEC on 2022-08-11.
Open-market sale of $1.8M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.92 | 11,859 | $521K | 28.4% |
| 2 | $43.92 | 11,859 | $521K | 28.4% |
| 3 | $43.93 | 8,995 | $395K | 21.6% |
| 4 | $43.93 | 8,995 | $395K | 21.6% |
| Total | $43.92 avg | 41,708 | $1.8M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |